Martin Holst Lange

Novo Nordisk A/S

Insider activity · 24 months0 buys1 saleCumulative net flow

Dec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 salesNov 26 · 0 buys · 1 sale

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (1 ops.)

€457k

Latest filing published 05 Nov 2026 for Novo Nordisk A/S, €457k.

Filing timeline

BuySale

Martin Holst Lange

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Martin Holst Lange: trading record in brief

Only one filing by Martin Holst Lange is known so far (5 November 2026): an open-market sale, €457k, in Novo Nordisk A/S. That is too little to draw conclusions. This summary is built from Finanstilsynet DK disclosures alone and does not predict where the share price will go.

Companies and markets linked to Martin Holst Lange

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Novo Nordisk A/S (DK)

Declarations1 total

▼
Martin Holst Lange
Scientific Officer (CSO)Executives5 Nov 2026Novo Nordisk A/S
3M DKK0DK FSA
12,000 shares@ DKK 285.00ShareISIN DK0062498333DK:1475306

1 of 1 declaration

Martin Holst Lange

Insider track record

Martin Holst Lange: trading record in brief

Companies and markets linked to Martin Holst Lange

Similar companies

Related executives